Philip Morris International: money over morality?

Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Bur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2019-08, Vol.394 (10200), p.709-709
1. Verfasser: The Lancet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 709
container_issue 10200
container_start_page 709
container_title The Lancet (British edition)
container_volume 394
creator The Lancet
description Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Burden of Disease Study, in 2015 alone, smoking caused more than one in ten deaths worldwide and killed more than 6 million people, resulting in a global loss of nearly 150 million disability-adjusted life-years. With sales of more than 740 billion cigarettes each year, 90% of revenue stemming from cigarette sales, rising sales and expanding market share in developing countries, aggressive lobbying, and relentless efforts to curtail controls and restrictions on smoking put in place to protect the public, never has there been so duplicitous or nonsensical a corporate manoeuvre as PMI's campaign in promoting a smoke-free future while whitewashing its role in subverting global tobacco control efforts.
doi_str_mv 10.1016/S0140-6736(19)31998-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283989147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673619319981</els_id><sourcerecordid>2283989147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-fba6db93cbf2cd6e2388d62b34b7a632e8c31d4a50ea4a48eef1f8e7e10afaea3</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_glLwUg-rmU12N-ulSPGjUFFQwVvIZmcxZbupybbQf2_6YQ9ePM0cnvcd5iHkHOg1UEhv3ihwGqUZSweQXzHIcxHBAekCz3iU8OzzkHT3SIeceD-llPKUJsekwwIluEi6BF6_TG3m_WfrnPH9cdOia1RrbKPq2_7MNrjq2yW6sDpVm3Y1PCVHlao9nu1mj3w83L-PnqLJy-N4dDeJNOe0japCpWWRM11UsS5TjJkQZRoXjBeZSlmMQjMouUooKq64QKygEpghUFUpVKxHBtveubPfC_StnBmvsa5Vg3bhZRwLlos8fBLQyz_o1C7CG_WGijkAzWmgki2lnfXeYSXnzsyUW0mgcu1UbpzKtTAJudw4lRByF7v2RTHDcp_6lRiA4RbAoGNp0EmvDTYaS-NQt7K05p8TP1bfhfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2282411090</pqid></control><display><type>article</type><title>Philip Morris International: money over morality?</title><source>Elsevier ScienceDirect Journals</source><creator>The Lancet</creator><creatorcontrib>The Lancet</creatorcontrib><description>Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Burden of Disease Study, in 2015 alone, smoking caused more than one in ten deaths worldwide and killed more than 6 million people, resulting in a global loss of nearly 150 million disability-adjusted life-years. With sales of more than 740 billion cigarettes each year, 90% of revenue stemming from cigarette sales, rising sales and expanding market share in developing countries, aggressive lobbying, and relentless efforts to curtail controls and restrictions on smoking put in place to protect the public, never has there been so duplicitous or nonsensical a corporate manoeuvre as PMI's campaign in promoting a smoke-free future while whitewashing its role in subverting global tobacco control efforts.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(19)31998-1</identifier><identifier>PMID: 31478485</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alternatives ; Cigarettes ; Consumers ; Developing countries ; Electronic cigarettes ; LDCs ; Low income areas ; Morality ; Public health ; Smoke ; Smoking ; Tobacco ; Young adults</subject><ispartof>The Lancet (British edition), 2019-08, Vol.394 (10200), p.709-709</ispartof><rights>2019 Elsevier Ltd</rights><rights>2019. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-fba6db93cbf2cd6e2388d62b34b7a632e8c31d4a50ea4a48eef1f8e7e10afaea3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673619319981$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31478485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>The Lancet</creatorcontrib><title>Philip Morris International: money over morality?</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Burden of Disease Study, in 2015 alone, smoking caused more than one in ten deaths worldwide and killed more than 6 million people, resulting in a global loss of nearly 150 million disability-adjusted life-years. With sales of more than 740 billion cigarettes each year, 90% of revenue stemming from cigarette sales, rising sales and expanding market share in developing countries, aggressive lobbying, and relentless efforts to curtail controls and restrictions on smoking put in place to protect the public, never has there been so duplicitous or nonsensical a corporate manoeuvre as PMI's campaign in promoting a smoke-free future while whitewashing its role in subverting global tobacco control efforts.</description><subject>Alternatives</subject><subject>Cigarettes</subject><subject>Consumers</subject><subject>Developing countries</subject><subject>Electronic cigarettes</subject><subject>LDCs</subject><subject>Low income areas</subject><subject>Morality</subject><subject>Public health</subject><subject>Smoke</subject><subject>Smoking</subject><subject>Tobacco</subject><subject>Young adults</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_glLwUg-rmU12N-ulSPGjUFFQwVvIZmcxZbupybbQf2_6YQ9ePM0cnvcd5iHkHOg1UEhv3ihwGqUZSweQXzHIcxHBAekCz3iU8OzzkHT3SIeceD-llPKUJsekwwIluEi6BF6_TG3m_WfrnPH9cdOia1RrbKPq2_7MNrjq2yW6sDpVm3Y1PCVHlao9nu1mj3w83L-PnqLJy-N4dDeJNOe0japCpWWRM11UsS5TjJkQZRoXjBeZSlmMQjMouUooKq64QKygEpghUFUpVKxHBtveubPfC_StnBmvsa5Vg3bhZRwLlos8fBLQyz_o1C7CG_WGijkAzWmgki2lnfXeYSXnzsyUW0mgcu1UbpzKtTAJudw4lRByF7v2RTHDcp_6lRiA4RbAoGNp0EmvDTYaS-NQt7K05p8TP1bfhfA</recordid><startdate>20190831</startdate><enddate>20190831</enddate><creator>The Lancet</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20190831</creationdate><title>Philip Morris International: money over morality?</title><author>The Lancet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-fba6db93cbf2cd6e2388d62b34b7a632e8c31d4a50ea4a48eef1f8e7e10afaea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alternatives</topic><topic>Cigarettes</topic><topic>Consumers</topic><topic>Developing countries</topic><topic>Electronic cigarettes</topic><topic>LDCs</topic><topic>Low income areas</topic><topic>Morality</topic><topic>Public health</topic><topic>Smoke</topic><topic>Smoking</topic><topic>Tobacco</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>The Lancet</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>British Nursing Index</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>Biological Sciences</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>The Lancet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Philip Morris International: money over morality?</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2019-08-31</date><risdate>2019</risdate><volume>394</volume><issue>10200</issue><spage>709</spage><epage>709</epage><pages>709-709</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Burden of Disease Study, in 2015 alone, smoking caused more than one in ten deaths worldwide and killed more than 6 million people, resulting in a global loss of nearly 150 million disability-adjusted life-years. With sales of more than 740 billion cigarettes each year, 90% of revenue stemming from cigarette sales, rising sales and expanding market share in developing countries, aggressive lobbying, and relentless efforts to curtail controls and restrictions on smoking put in place to protect the public, never has there been so duplicitous or nonsensical a corporate manoeuvre as PMI's campaign in promoting a smoke-free future while whitewashing its role in subverting global tobacco control efforts.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31478485</pmid><doi>10.1016/S0140-6736(19)31998-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2019-08, Vol.394 (10200), p.709-709
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_2283989147
source Elsevier ScienceDirect Journals
subjects Alternatives
Cigarettes
Consumers
Developing countries
Electronic cigarettes
LDCs
Low income areas
Morality
Public health
Smoke
Smoking
Tobacco
Young adults
title Philip Morris International: money over morality?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T23%3A20%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Philip%20Morris%20International:%20money%20over%20morality?&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=The%20Lancet&rft.date=2019-08-31&rft.volume=394&rft.issue=10200&rft.spage=709&rft.epage=709&rft.pages=709-709&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(19)31998-1&rft_dat=%3Cproquest_cross%3E2283989147%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2282411090&rft_id=info:pmid/31478485&rft_els_id=S0140673619319981&rfr_iscdi=true